标题: Imperial College Spinout OSSTEC Raises $8 Million for 3D Printed Cementless Knee Implants [打印本页] 作者: admin 时间: 2026-11-14 20:10 标题: Imperial College Spinout OSSTEC Raises $8 Million for 3D Printed Cementless Knee Implants Nanjixiong introduction: Knee replacement is a common orthopedic procedure, and conventional implants are often secured with bone cement. U.K. company OSSTEC is pursuing metal 3D printed implants with biomimetic porous structures that allow bone to grow into the implant, removing the need for cement. The company recently raised $8 million to advance a U.S. launch.
On November 3, 2026, Nanjixiong learned that OSSTEC had raised $8 million to advance development of its cementless joint replacement implants and bring them to the United States.
(, 下载次数: 0)
上传
点击文件名下载附件
A cementless knee implant team spun out of Imperial College London
Founded in 2021 as a spinout from Imperial College London, OSSTEC uses metal additive manufacturing to develop cementless joint replacement implants. London-based EMBRYO Ventures led the round, with participation from Neovate Capital, New Wave Ventures, OTIF Ventures and Empirical Ventures.
OSSTEC's lead product, ASCENT, is a cementless unicompartmental knee arthroplasty (UKA) system paired with CLARITY surgical instruments. Its implant base uses an additively manufactured biomimetic fixation platform designed for biological fixation without bone cement. The articulating surface and fixation structure are made together in one manufacturing process.
(, 下载次数: 0)
上传
点击文件名下载附件
FDA clearance pending, with first U.S. surgeries planned for the first half of 2027
OSSTEC says the funds will support continued development of ASCENT and CLARITY through U.S. FDA clearance. It plans its first U.S. procedures in humans in the first half of 2027. At the time of the announcement, neither ASCENT nor CLARITY had FDA clearance or was sold in the United States.
Founder and CEO Dr. Max Munford said the financing shifts the company's focus from preparation toward patients. Surgeons have told the company they would consider unicompartmental replacement for more patients if a next-generation cementless option were available. ASCENT is designed around a relatively familiar, streamlined surgical approach. OSSTEC also has a pipeline of cementless products beyond the knee.
EMBRYO Ventures CEO Arash Moavenian said that as the next-generation implant approaches its first clinical use, the firm is backing OSSTEC's efforts to improve patient outcomes and operating efficiency.
Nanjixiong's observations
Porous titanium alloys and biomimetic structures that support bone ingrowth are among the more established uses of metal 3D printing in orthopedic implants. Unicompartmental replacement addresses only the damaged side of the knee and is relatively less invasive, but requires secure fixation and a precise fit. OSSTEC is still in the regulatory and early clinical stages. FDA clearance, clinical data and production capacity validation remain ahead before U.S. commercialization. The financing is intended to take the team through that period.
AI-translated from an article by Kuaixiong on Nanjixiong, originally published on 2026-11-13. Text and images retain the original source attribution. Read the original Chinese article
欢迎光临 All Voice of China 3D Printing (https://www.panda3dp.com/)